Home
Scholarly Works
A phase II study of patupilone in patients with...
Conference

A phase II study of patupilone in patients with metastatic hormone refractory prostate cancer (HRPC) who have progressed after docetaxel

Authors

Chi KN; Beardsley EK; Venner PM; Eigl BJ; Hotte SJ; Ko Y; Saad F; Winquist E

Volume

26

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2008

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team